Omicron subvariants are now dominant in the U.S. as COVID cases tick up and New York City becomes a hot spot
admin Omicron subvariants continued to account for more new cases of COVID-19 in the U.S. in…
Read MorePFE
FDA to allow bivalent COVID boosters for some infants and young children
The Food and Drug Administration on Thursday authorized the bivalent COVID-19 boosters made by Moderna…
Read MoreIMF head joins chorus calling on China to adapt COVID strategy as officials pledge to boost vaccinations among elderly
The head of the International Monetary Fund on Tuesday joined the chorus of people urging…
Read MoreChina’s zero-COVID strategy makes no sense and its homegrown vaccines are not ‘particularly effective,’ says Fauci
Widespread protests across China over the government’s zero-COVID policy dominated pandemic headlines Monday, with Anthony…
Read MoreChina’s three-week COVID case tally tops 253,000 and daily average is rising, government says
More than 253,000 coronavirus cases have been found in China in the past three weeks…
Read MoreConfused about COVID boosters? Here’s what the science and the experts say about the new generation of shots.
As we head into the third winter of the pandemic, only about 13% of American…
Read MorePfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of data
A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster…
Read MoreWHO says 90% decline in COVID deaths since Feb. is ’cause for optimism,’ while urging vigilance against new variants
The head of the World Health Organization said a close to 90% decline in COVID…
Read MoreWHO says 90% decline in COVID deaths since Feb. is ’cause for optimism,’ while urging vigilance against new variants
The head of the World Health Organization said a close to 90% decline in COVID…
Read More
This fund beats the S&P 500 by using 75 of its stocks. Here’s how it works.
What worked well during the years-long bull market through 2021 — a focus on growth,…
Read More